| SYK |
Report |
Organic Revenue Growth (Q2 2026) |
BEAT |
pred ~10.5-11% vs. cons 9.3% |
MEDIUM |
| SYK |
Report |
Adj. EPS - Diluted Operating (Q2 2026) |
BEAT |
pred ~$3.57 vs. cons $3.47 |
MEDIUM |
| SYK |
Report |
Mako Installations (Q2 2026) |
BEAT |
pred ~105-115 units vs. cons 98 units |
MEDIUM |
| SYK |
Guide |
FY 2026 Organic Growth (FY 2026) |
UNCHANGED |
guide ~8-9.5% (maintain) vs. cons 8.81% |
HIGH |
| SYK |
Guide |
FY 2026 Adj. EPS (FY 2026) |
UNCHANGED |
guide ~$14.90-$15.10 (maintain) vs. cons $14.98 |
HIGH |
| SYK |
Guide |
Gross/Op Margin Recovery Commentary (FY 2026) |
BETTER |
Q2 gross margin recovery toward 65%+; 150bps+ op margin expansion on track |
MEDIUM |
| SYK |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.5% |
— |
MEDIUM |
| SYK |
Return |
5-day cumulative residual |
-1.0% (FADE) |
FADE - maintained FY guide (not a raise) + elevated pre-print run limits follow-through; H2 recovery still a show-me story |
MEDIUM |